Get the Stockscreener App
2.27
0.89%
0.02
After Hours:
2.26
-0.01
-0.44%
Eledon Pharmaceuticals Inc Stock (ELDN) Forecast
The Eledon Pharmaceuticals Inc (ELDN) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $2.6564, representing a +17.02% increase from the current price of $2.27. The highest analyst price target is $3.259, and the lowest is $2.0537.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month ELDN Price Target
Average 1.6316
(-28.12% Downside)
Is Eledon Pharmaceuticals Inc (ELDN) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 28.20 | Buy |
| STOCH(9,6) | 20.97 | Neutral |
| STOCHRSI(14) | 20.25 | Neutral |
| MACD(12,26) | -0.1722 | Buy |
| ADX(14) | 17.87 | Neutral |
| William %R | -86.69 | Buy |
| CCI(14) | -81.68 | Neutral |
Buy: 3
Sell: 0
Neutral: 4
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
2.406
Sell
|
2.3968
Sell
|
| MA20 |
2.5208
Sell
|
2.5189
Sell
|
| MA50 |
2.9503
Sell
|
2.8445
Sell
|
| MA100 |
3.3407
Sell
|
3.0667
Sell
|
| MA200 |
3.0686
Sell
|
3.0967
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, ELDN could be considered a Strong Sell, with 17 technical analysis indicators signaling 3 Buy signals, 10 signaling Sell signals and 4 Neutral signals. This might not be a good time to consider opening new positions on ELDN, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 28.2 indicates that ELDN is oversold. This indicates that ELDN price has experienced a significant decline over a specified lookback period, potentially leading to a rebound.
- STOCH (Stochastic Oscillator): The STOCH value of 20.97 indicates that ELDN is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 20.25 indicates that ELDN is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 17.87 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -81.68 indicates that ELDN is still oversold but not to an extreme extent.
Long-term ELDN price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Eledon Pharmaceuticals Inc financial reports and earnings history, Eledon Pharmaceuticals Inc (ELDN) stock could reach $1.0795 by 2030, $5.3218 by 2040 and $10.29 by 2050. See the projected annual prices until 2050 of the Eledon Pharmaceuticals Inc stock below:
- Eledon Pharmaceuticals Inc (ELDN) is expected to reach an average price of $2.3762 in 2035, with a high prediction of $2.4082 and a low estimate of $2.4472. This indicates an $4.68% rise from the last recorded price of $2.27.
- Eledon Pharmaceuticals Inc (ELDN) stock is projected to chart a bullish course in 2040, with an average price target of $5.4046, representing an $138.09% surge from its current level. The forecast ranges from a conservative $5.4176 to a sky-high $5.3218.
- Our analysts predict Eledon Pharmaceuticals Inc (ELDN) to jump 220.25% by 2045, soaring from $7.3817 to an average price of $7.2697, potentially reaching $7.2745. While $7.3817 is the low estimate, the potential upside is significant.
- Eledon Pharmaceuticals Inc (ELDN) stock is expected to climb by 2050, reaching an average of $9.5217, a $319.46% jump from its current level. However, a wide range of estimates exists, with high and low targets of $10.29 and $10.32, respectively, highlighting the market's uncertainty.
Eledon Pharmaceuticals Inc Stock (ELDN) Year by Year Forecast
Eledon Pharmaceuticals Inc Stock (ELDN) Price Forecast for 2026
The predicted value for Eledon Pharmaceuticals Inc (ELDN) in 2026 is set at an average of $2.7699. Estimates vary from a peak of $4.4899 to a trough of $1.05, indicating an +22.02% surge from the present price of $2.27.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| November, 2026 | $2.1195 | $2.0537 | $3.259 | -6.63% |
| December, 2026 | $1.8805 | $1.05 | $2.3147 | -17.16% |
Eledon Pharmaceuticals Inc Stock (ELDN) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Eledon Pharmaceuticals Inc (ELDN) is $1.2061, with a high forecast of $2.408 and a low forecast of $0.00422. This indicates an -46.87% decrease from the last price of $2.27.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $1.0115 | $0.9366 | $2.408 | -55.44% |
| February, 2027 | $1.4725 | $0.6367 | $1.5925 | -35.13% |
| March, 2027 | $0.7187 | $0.4487 | $1.6877 | -68.34% |
| April, 2027 | $1.2997 | $0.2439 | $1.4844 | -42.75% |
| May, 2027 | $0.1959 | $0.00422 | $1.3277 | -91.37% |
| June, 2027 | $0.5769 | $0.1517 | $1.3369 | -74.59% |
| July, 2027 | $0.0979 | $0.1074 | $1.2276 | -95.69% |
| August, 2027 | $0.1341 | $0.0905 | $0.8541 | -94.09% |
| September, 2027 | $0.6751 | $0.1444 | $1.1806 | -70.26% |
| October, 2027 | $1.0061 | $0.4742 | $1.3993 | -55.68% |
| November, 2027 | $0.0351 | $0.0829 | $1.2014 | -98.45% |
| December, 2027 | $0.0667 | $0.1174 | $0.3626 | -97.06% |
Eledon Pharmaceuticals Inc Stock (ELDN) Price Forecast for 2028
In 2028, Eledon Pharmaceuticals Inc (ELDN) is projected to reach an average price of $0.6584, with a high projection of $1.2863 and a low estimate of $0.0304. This indicates an -71.00% fall from the last price of $2.27.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $0.0596 | $0.0304 | $0.3938 | -97.38% |
| February, 2028 | $0.1494 | $0.1147 | $0.3653 | -93.42% |
| March, 2028 | $0.8815 | $0.0412 | $1.2863 | -61.17% |
| April, 2028 | $0.2625 | $0.1826 | $1.0641 | -88.43% |
| May, 2028 | $0.1312 | $0.0717 | $0.281 | -94.22% |
| June, 2028 | $0.0998 | $0.1506 | $0.3293 | -95.61% |
| July, 2028 | $0.014 | $0.0308 | $0.6308 | -99.38% |
| August, 2028 | $0.443 | $0.4083 | $0.2183 | -80.48% |
| September, 2028 | $0.902 | $0.7378 | $0.7673 | -60.26% |
| October, 2028 | $0.9568 | $0.9468 | $0.8611 | -57.85% |
| November, 2028 | $0.7048 | $0.8148 | $0.9106 | -68.95% |
| December, 2028 | $0.9938 | $0.8096 | $0.9038 | -56.22% |
Eledon Pharmaceuticals Inc Stock (ELDN) Price Forecast for 2029
The 2029 price forecast for Eledon Pharmaceuticals Inc Stock (ELDN) is $0.6998 on average, with a high prediction of $1.3987 and a low estimate of $0.000835. This represents an -69.17% decrease from the previous price of $2.27.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $0.5835 | $0.7811 | $0.7886 | -74.30% |
| February, 2029 | $0.8866 | $0.6823 | $0.8618 | -60.94% |
| March, 2029 | $0.8656 | $1.0156 | $0.9808 | -61.87% |
| April, 2029 | $0.3793 | $0.3546 | $0.5903 | -83.29% |
| May, 2029 | $0.3584 | $0.3536 | $0.3041 | -84.21% |
| June, 2029 | $0.2674 | $0.2674 | $0.2432 | -88.22% |
| July, 2029 | $0.0189 | $0.0611 | $0.2784 | -99.17% |
| August, 2029 | $0.0398 | $0.1102 | $0.2606 | -98.24% |
| September, 2029 | $1.0208 | $0.000835 | $1.2892 | -55.03% |
| October, 2029 | $0.7571 | $0.3113 | $1.3551 | -66.65% |
| November, 2029 | $0.7481 | $0.3428 | $0.8981 | -67.05% |
| December, 2029 | $0.8043 | $0.4333 | $1.3987 | -64.57% |
Eledon Pharmaceuticals Inc Stock (ELDN) Price Forecast for 2030
Eledon Pharmaceuticals Inc Stock (ELDN) is expected to reach an average price of $2.0843 in 2030, with a high forecast of $3.6825 and a low forecast of $0.486. This signifies an -8.18% decrease from the last price of $2.27.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $0.7453 | $0.51 | $1.0795 | -67.17% |
| February, 2030 | $0.7363 | $0.486 | $0.7863 | -67.56% |
| March, 2030 | $2.7873 | $0.6815 | $2.8973 | +22.79% |
| April, 2030 | $2.8235 | $1.9183 | $3.6825 | +24.38% |
| May, 2030 | $2.5345 | $2.1292 | $3.254 | +11.65% |
| June, 2030 | $2.2255 | $1.8855 | $3.175 | -1.96% |
| July, 2030 | $2.5217 | $2.2017 | $3.1862 | +11.09% |
| August, 2030 | $1.7627 | $1.5527 | $2.707 | -22.35% |
| September, 2030 | $1.2689 | $0.8837 | $1.918 | -44.10% |
| October, 2030 | $1.1899 | $1.1499 | $1.8442 | -47.58% |
| November, 2030 | $1.4009 | $1.1253 | $1.5859 | -38.29% |
| December, 2030 | $1.4272 | $0.9367 | $1.5072 | -37.13% |
1.35%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):